127 related articles for article (PubMed ID: 445860)
1. Electroencephalographic change in Parkinsonian patients treated with levodopa-carbidopa.
Stephens R; Green J; Haycook W; Kilgore M
Clin Electroencephalogr; 1979 Jan; 10(1):31-4. PubMed ID: 445860
[TBL] [Abstract][Full Text] [Related]
2. The long-term effects of combining carbidopa with levodopa for Parkinson's disease.
Lee MC; Lippert DM; Loewenson RB; Tolosa ES; Resch JA; Martin WE
Trans Am Neurol Assoc; 1976; 101():262-4. PubMed ID: 829295
[No Abstract] [Full Text] [Related]
3. Effect of a slow release preparation of levodopa on Parkinson's disease in combination with a peripheral decarboxylase inhibitor.
Saarinen A; Myllylä VV; Tokola O; Hokkanen E
Acta Neurol Scand; 1978 Dec; 58(6):340-9. PubMed ID: 369277
[TBL] [Abstract][Full Text] [Related]
4. Levodopa with benserazide or carbidopa in Parkinson disease.
Rinne UK; Mölsä P
Neurology; 1979 Dec; 29(12):1584-9. PubMed ID: 574221
[TBL] [Abstract][Full Text] [Related]
5. Combined use of benserazide and carbidopa in Parkinson's disease.
Lieberman AN; Goldstein M; Gopinathan G; Neophytides A; Hiesiger E; Walker R; Nelson J
Neurology; 1984 Feb; 34(2):227-9. PubMed ID: 6538015
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease.
Lieberman A; Goodgold A; Jonas S; Leibowitz M
Neurology; 1975 Oct; 25(10):911-6. PubMed ID: 1101099
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
Lombardo L; De la Garza R
Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
[TBL] [Abstract][Full Text] [Related]
8. [Carbiodopa-levodopa therapy (Sinemet) in the treatment of parkinsonian patients. Results of 4 years of treatment].
Martínez-Lage JM; Burguera JA; Deldago G; Zubieta JL
Arch Neurobiol (Madr); 1978; 41(1):3-18. PubMed ID: 697513
[No Abstract] [Full Text] [Related]
9. A comparative clinical investigation of the therapeutic effect of levodopa alone and in combination with a decarboxylase inhibitor (carbidopa) in cases of Parkinson's disease.
Wajsbort J; Dorner A; Wajsbort E
Curr Med Res Opin; 1978; 5(9):695-708. PubMed ID: 367714
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Parkinson's syndromes by a combination of levodopa with decarboxylase inhibitors].
Hanzal F
Cesk Neurol Neurochir; 1975 Dec; 38(6):327-32. PubMed ID: 1192544
[No Abstract] [Full Text] [Related]
11. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
Savery F
Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
[No Abstract] [Full Text] [Related]
12. L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease.
Glasgow GL; Henley JW; Willoughby EW
Aust N Z J Med; 1974 Aug; 4(4):373-8. PubMed ID: 4278910
[No Abstract] [Full Text] [Related]
13. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
Londoõ R
Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729
[TBL] [Abstract][Full Text] [Related]
14. Comparison of levodopa with carbidopa or benserazide in parkinsonism.
Greenacre JK; Coxon A; Petrie A; Reid JL
Lancet; 1976 Aug; 2(7982):381-4. PubMed ID: 73849
[TBL] [Abstract][Full Text] [Related]
15. [Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease].
Rondot P
Rev Prat; 1974 Mar; 24(15):1211-2, 1215-6, 1219. PubMed ID: 4416964
[No Abstract] [Full Text] [Related]
16. Letter: Alternatives to levodopa.
Hildick-Smith M
Br Med J; 1976 Jun; 1(6022):1406. PubMed ID: 1276722
[No Abstract] [Full Text] [Related]
17. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
Meco G; Casacchia M; Zamponi A; Agnoli A
Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
[No Abstract] [Full Text] [Related]
18. [Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)].
Hanzal F
MMW Munch Med Wochenschr; 1976 May; 118(20):653-6. PubMed ID: 818540
[TBL] [Abstract][Full Text] [Related]
19. The clinical picture and plasma levodopa metabolite profile of parkinsonian nonresponders. Treatment with levodopa and decarboxylase inhibitor.
Rivera-Calimlim L; Tandon D; Anderson F; Joynt R
Arch Neurol; 1977 Apr; 34(4):228-32. PubMed ID: 843257
[TBL] [Abstract][Full Text] [Related]
20. Alpha methyldopahydrazine as an adjunct to levodopa therapy in Parkinson's disease.
Paty DW; Jaatoul N; Kertesz A; McInnis W
Can J Neurol Sci; 1975 Aug; 2(3):169-72. PubMed ID: 1100213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
